Butene

Repeated dose toxicity: inhalation

Administrative data

Endpoint:

short-term repeated dose toxicity: inhalation

Remarks:

combined repeated dose and reproduction / developmental screening

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP compliant, guideline study, available as unpublished report, fully adequate for assessment

Cross-reference

Cross-reference 1

Reason / purpose for cross-reference:

reference to same study

Cross-reference 2

Reason / purpose for cross-reference:

reference to other study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1992

Report date:

1992

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)

Deviations:

yes

Remarks:

the deviations were considered not to have influenced the outcome of the study

Principles of method if other than guideline:

not applicable

GLP compliance:

yes (incl. QA statement)

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

Reference substance 002

Cas Number:

107-01-7

Molecular formula:

C4H8

Constituent 2

Reference substance name:

butene-2

IUPAC Name:

butene-2

Details on test material:

- Name of test material (as cited in study report): butene-2
- Physical state: gas
- Analytical purity: cis & trans-2-butene ≤95%
- Molecular weight: 56.1
- Boiling point: 4°C
- Melting point: -139°C
- Vapour pressure: 2.5 bars at 20°C
- Explosive limits in air: 1.6 - 10%

Test animals

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Charles River Wiga GmbH, Sulzfeld, F.R.G
- Age at study initiation: Approximately 12 weeks
- Weight at study initiation: 278.8 - 321.6 g (mean 299.4g) for males and 191.5 - 219.0 g (mean 204.0 g) for females
- Fasting period before study: None
- Housing: 4 per sex/cage prior to exposure, and individually after mating, in suspended stainless steel cages.
- Diet: Stock diet ad libitum except for about 30 minutes prior to, and during exposure.
- Water: ad libitum except for about 30 minutes prior to, and during exposure.
- Acclimation period: 13 days

ENVIRONMENTAL CONDITIONS
- Temperature: 20-23°C
- Humidity: 37-80% (with occasional higher values after cleaning)
- Air changes: 10 per hr
- Photoperiod: 12 hrs dark /12 hrs light

IN-LIFE DATES: From: 30 January 1992 To: 15 March 1992

Administration / exposure

Route of administration:

inhalation: gas

Type of inhalation exposure:

whole body

Vehicle:

other: air

Remarks on MMAD:

MMAD / GSD: no data

Details on inhalation exposure:

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Modified H 1000 multitiered inhalation chambers manufactured by Hazleton Systems Inc., USA. Stainless steel, with glass doors, with a capacity of approximately 2.2 m3
- Method of holding animals in test chamber: Individually in wire mesh stainless steel cages
- Each chamber was fitted with a micromanometer which showed the negative pressure inside ( 1-4 mm water column).
- To generate the test atmospheres, the test material was passed from the cylinder via a pressure reducer, stainless steel tubing and two calibrated massflow controllers and rotameters to the inlet of the inhalation chambers, where they were diluted with filtered air from the air conditioning system to the desired concentrations. The atmospheres were directed downward to the location of the animals.
- At the bottom of the chamber the test atmosphere was exhausted.
- Control rats were exposed to filtered air only.

TEST ATMOSPHERE
- Brief description of analytical method used: The test atmosphere samples were taken sequentially from each of the chambers (control chamber included). They were drawn through heated sampling lines and were passed via a controlled valves system (Kuax-Control, Kuhnke 61.000) to the total carbon analyser (Ratfisch RS 55, FRG). The response of the analyser was recorded by a Kipp analogue recorder.
- The concentration was determined approximately twice each hour in each test atmosphere. Samples were taken from the chambers at a location close to the cage units in which the animals were housed.
- During preliminary experiments, it was checked whether a uniform distribution was obtained by measuring the concentration at several locations.
- The response of the total carbon analyser was recorded in scale units and converted into concentration values (ppm) based on the response of the calibration mixtures.
- The nominal concentration was determined using the mean amount of test material used per hour divided by the mean hourly volume of air passed through the exposure chamber (control chamber excluded).

Analytical verification of doses or concentrations:

yes

Details on analytical verification of doses or concentrations:

The mean actual concentrations (± standard deviation) of butene-2 in the test atmospheres were 2476 (68) and 5009 (88) ppm, or 5.7 and 11.5 g/m3, for the low- and high-concentration respectively.

Duration of treatment / exposure:

Exposure: daily during the premating period (2 weeks), through mating (1 week) and gestation (up to and including day 19)
Study duration was 39-46 days for both males and females

Frequency of treatment:

6 hrs/day

Doses / concentrations

Doses / concentrations 1

Remarks:

Doses / Concentrations:
0, 2500 or 5000 ppm
Basis:
other: target concentration

Doses / concentrations 2

Remarks:

Doses / Concentrations:
0, 2476 or 5009 ppm
Basis:
analytical conc.

Doses / concentrations 3

Remarks:

Doses / Concentrations:
5.7 and 11.5 g/m3
Basis:
analytical conc.

No. of animals per sex per dose:

12

Control animals:

yes, sham-exposed

Details on study design:

as above

Positive control:

none

Examinations

Observations and examinations performed and frequency:

CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: As necessary, to appraise physical condition.

BODY WEIGHT: Yes
- Time schedule for examinations: Male rats were weighed weekly. Female rats were weighed weekly during the premating period, on days 0, 7, 14 and 21 of pregnancy and on day 1 and 4 post partum.

FOOD CONSUMPTION:
- Food consumption was measured weekly (the second week during premating over a 6-day period) during the premating period in both males and females. Food consumption of parent females was also recorded weekly during pregnancy and through day 1-4 of lactation. Food consumption of parent males and not-mated females was recorded weekly after the mating period until scheduled sacrifice.

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION: No

OPHTHALMOSCOPIC EXAMINATION: No

HAEMATOLOGY: Yes
- Time schedule for collection of blood: At autopsy
- Anaesthetic used for blood collection: Yes; ether anaesthesia
- Animals fasted: No data
- How many animals: All F0 animals
- Parameters checked: haemoglobin, packed cell volume, red blood cell count, red blood cell distribution width (RDW-SD), reticulocyte count, total white blood cell count, differential white blood cell count, prothrombin time, thrombocyte count, mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC).

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: At autopsy
- Animals fasted: No data
- How many animals: All F0 animals
- Parameters checked: alanine amino transferase (ALAT)/glutamic-pyruvic transaminase (GPT), albumin, aspartate amino transferase (ASAT), bilirubin total, calcium (Ca), chloride (Cl), creatinine, y-glutamyl transferase (yGT), inorganic phosphate, potassium (K), sodium (Na), total protein, urea.

URINALYSIS: No

NEUROBEHAVIOURAL EXAMINATION: No

OTHER:
- The total litter size and numbers of each sex as well as number of stillbirths and grossly malformed pups were recorded on days1 and 4 post partum.
- The litters were weighed on days 1 and 4

Sacrifice and pathology:

GROSS PATHOLOGY: Yes
- All male and female parent rats were killed by exsanguination from the abdominal aorta under ether anaesthesia. A complete gross examination was performed.
- The following organs were weighed: testes, epididymides, liver, kidneys, thymus, lungs with trachea and larynx.
- Pregnancy was demonstrated on the basis of implantation sites observed at autopsy of the female rats.

HISTOPATHOLOGY: Yes
- The following organs were examined microscopically from control and 5000 ppm animals: testes, epididymides, liver, kidneys, thymus, lungs with trachea and larynx, ovaries, uterus, seminal vesicles, adrenals, brain, heart, spleen, nose and any abnormal tissues and organs.

OFFSPRING:
- A necropsy was performed on stillborn pups and pups dying during the study; macroscopic abnormalities were recorded. Pups killed on day 4 were also examined macroscopically

Other examinations:

none

Statistics:

Parental clinical findings, mating and litter data, and pathological changes were evaluated by Fisher's exact probability test; bodyweight and food consumption by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison tests. Duration of gestation, litter size implantations and pre- and post-implantation loss were evaluated by Kruskal-Wallis nonparametric analysis of variance followed by the Mann-Whitney U-test, and pup bodyweights by analysis of variance followed by Dunnett's multiple comparison tests.

Results and discussion

Results of examinations

Clinical signs:

no effects observed

Mortality:

no mortality observed

Body weight and weight changes:

effects observed, treatment-related

Food consumption and compound intake (if feeding study):

effects observed, treatment-related

Food efficiency:

not specified

Water consumption and compound intake (if drinking water study):

not examined

Ophthalmological findings:

not examined

Haematological findings:

no effects observed

Clinical biochemistry findings:

no effects observed

Urinalysis findings:

not examined

Behaviour (functional findings):

not examined

Organ weight findings including organ / body weight ratios:

no effects observed

Gross pathological findings:

no effects observed

Histopathological findings: non-neoplastic:

no effects observed

Histopathological findings: neoplastic:

no effects observed

Details on results:

BODY WEIGHT AND WEIGHT GAIN
Mean body weights of the males were comparable in all groups. Some slight differences in body weight change were observed. Fourteen days and 7 and 14 days after the start of exposure to 2500 and 5000 ppm respectively, female rats showed statistically significantly decreased mean body weights compared with controls. No effects on body weights of females were observed during gestation. On day 1 of lactation the mean body weight of the females of the 5000 ppm group was statistically significantly decreased. No effects on body weight change of the females was observed during the study.

FOOD CONSUMPTION
There was a statistically significantly decreased food intake of the females of the 5000 ppm group during the first week of the premating period only.

HAEMATOLOGY
In males, total white blood cell count and the number of lymphocytes were increased in both groups exposed to butene-2. However, there was no dose-response relationship, and the values found in the test groups (8.2± 0.5, 8.0± 0.4) were within the range of historical control values (9.9± 1.7) whereas the control value was quite low (6.3 ± 0.4). Therefore, this effect was considered to be of no significance.

CLINICAL CHEMISTRY
In males of the 5000 ppm group plasma calcium concentration was slightly decreased. This was considered to be of no toxicological significance since this effect was not accompanied by a change of the inorganic phosphate levels.

Effect levels

Dose descriptor:

NOAEC

Remarks:

toxicity

Effect level:

5 000 other: ppm (11474 mg/m3, 11 mg/L) nominal

Sex:

male/female

Basis for effect level:

other: although there were some effects on body weight, these were small, not dose-related and not consistent throughout the study, 5000 ppm was the highest concentration tested

Target system / organ toxicity

Critical effects observed:

not specified

Any other information on results incl. tables

In the original report a NOAEL for toxicity was set at 2,500 ppm based on the slight effects on body weights in males and females, and possibly food consumption in females. A re-analysis of the data by RIVM (2009) (The Netherlands) concluded that as these effects were not dose-related and not consistently present during the study, the NOAEL for butene-2 should therefore be ≥5000 ppm.

 

The data in question is shown in Table 1.

 

• The changes in the body weight gain of the males was not considered to be adverse. It was only observed in week 1 and in week 4, when only the low dose was decreased, not showing a dose-response relationship. The change of 12 to 20 g, compared with the body weight of about 300 g is small. Furthermore, this effect was not observed in week 2 and 3, and no significant effects were shown on the body weight of the males.
• In females, the effect on food consumption was not accompanied by an effect on body weight.
• The effect on body weights of females was also not consistent through the whole study and was small (at the most about 5%).

 

Table 1. Treatment-related effects on body weight, body weight gain and food consumption

 

	0	2500 ppm	5000 ppm
MALES
Week 1 Body weight	317.9± 4.36	313.9± 2.91	314.4± 3.63
Weeks 0-1 Body weight change	21.78 ±1.56	12.66±1.20 (58.1%)**	13.48± 1.54 (61.9%)**
Week 5 Body weight	369.6± 6.70	361.8± 4.14	367.0± 4.59
Weeks 4-5 Body weight change	10.87±1.38	5.84±1.74 (53.7%)*	11.60±1.20 (106.7%)
FEMALES
Week 0 Body weight	205.33± 2.10	203.60± 1.55	203.15± 1.91
Week 1 Body weight	214.25± 2.23	210.83± 1.55 (98.4%)	207.79± 1.13 (97.0%)*
Weeks 0-1 Body weight change	8.93± 1.21	7.23± 1.43	4.64± 1.49
Week 2 Body weight	220.28± 2.13	212.78± 2.05 (96.6%)*	213.19± 1.42 (96.8%)*
Weeks 1-2 Body weight change	6.0± 1.46	1.94± 1.79	5.40± 1.00
Body weight Lactation Day 1	243.13±2.00	238.42±3.44 (98.1%)	230.61±2.67 (94.9%)*
Weeks 0-1 Food consumption	70.42±1.40	68.76±1.52 (97.6%)	65.28±0.96 (92.7%)*

Anova + Dunnet test; *= p, 0.05, **=p< 0.001

Applicant's summary and conclusion

Conclusions:

Male and female rats were exposed to 2-butene at target concentrations of 2500 or 5000 ppm ( 5737 or 11474 mg/m3) for two weeks prior to breeding, during breeding and until day 19 of gestation. There were no effects and therefore the NOAECs for this study were the highest concentration tested.

Executive summary:

Male and female rats were exposed to 2-butene at target concentrations of 2500 or 5000 ppm ( 5737 or 11474 mg/m3) for two weeks prior to breeding, during breeding (1 week) and until day 19 of gestation (39-46 days of exposure). No significant systemic toxicity occurred in either sex, or in pregnant female rats. Some decreases in body weight were observed in both sexes at 5000 ppm but no other treatment-related changes were observed. Mean absolute organ weight and relative weight were comparable in all groups. No abnormal, treatment-related macroscopic changes (all groups) or pathological changes (control and 5000 ppm groups) were observed. In the original report a NOAEL for toxicity was set at 2,500 ppm based on the slight effects on body weights in males and females, and possibly food consumption in females. A re-analysis of the data by RIVM (2009) however, concluded that as these effects were not dose-related and not consistently present during the study, therefore the NOAEL for this study is 5000 ppm.